Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Nanocellect Biomedical in September, 2019 for $745,729.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DA045460-02 | Phase II | 745,729 | September 15, 2019 | |||||||
A SBIR Phase I contract was awarded to Nanocellect Biomedical in March, 2018 for $224,935.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DA045460-01 | Phase I | 224,935 | March 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Nanocellect Biomedical in August, 2022 for $891,540.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44GM148128-01 | Phase II | 891,540 | August 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Nanocellect Biomedical in April, 2016 for $213,965.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DA042636-01 | Phase I | 213,965 | April 15, 2016 | |||||||
A SBIR Phase II contract was awarded to Nanocellect Biomedical in September, 2014 for $1,874,535.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM112442-03 | Phase II | 1,874,535 | September 1, 2014 | |||||||
A SBIR Phase I contract was awarded to Nanocellect Biomedical in September, 2015 for $224,599.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43EB021129-01 | Phase I | 224,599 | September 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Nanocellect Biomedical in September, 2017 for $1,571,914.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R44GM128223-02 | Phase II | 1,571,914 | September 8, 2017 | |||||||
A SBIR Phase II contract was awarded to Nanocellect Biomedical in September, 2017 for $1,499,912.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DA042636-02 | Phase II | 1,499,912 | September 30, 2017 | |||||||
A SBIR Phase I contract was awarded to Nanocellect Biomedical for $199,743.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO120072 | Phase I | 199,743 | ||||||||
A SBIR Phase I contract was awarded to Nanocellect Biomedical for $198,641.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO110096 | Phase I | 198,641 | ||||||||
A SBIR Phase II contract was awarded to Nanocellect Biomedical for $972,199.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R44GM103677-02 | Phase II | 972,199 | ||||||||
A SBIR Phase I contract was awarded to Nanocellect Biomedical for $691,523.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM109241-01 | Phase I | 691,523 | ||||||||
A SBIR Phase I contract was awarded to Nanocellect Biomedical for $166,196.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43RR031424-01 | Phase I | 166,196 | ||||||||
A SBIR Phase I contract was awarded to Nanocellect Biomedical for $697,999.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43RR032225-01 | Phase I | 697,999 |